Negative regulation of TGF-β receptor/Smad signal transduction

Current Opinion in Cell Biology

Volumn 19, Issue 2, 2007, Pages 176-184

  Itoh, Susumu ^a   ten Dijke, Peter ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CELLULAR DISTRIBUTION; EMBRYO DEVELOPMENT; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INACTIVATION; HOMEOSTASIS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 33847716712     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.02.015     Document Type: Review

References (63)

1. Massagué J., Blain S.W., and Lo R.S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
2. ten Dijke P., and Hill C.S. New insights into TGF-β-Smad signalling. Trends Biochem Sci 29 (2004) 265-273
3. Di Guqlielmo G.M., Le Roy C., Goodfellow A.F., and Wrana J.L. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5 (2003) 410-421
4. Lin H.-K., Bergmann S., and Pandolfi P.P. Cytoplasmic PML function in TGF-β signalling. Nature 431 (2004) 205-211
5. Lu Z., Murray J.T., Luo W., Li H., Wu X., Xu H., Backer J.M., and Chen Y.G. Transforming growth factor β activates Smad2 in the absence of receptor endocytosis. J Biol Chem 277 (2002) 29363-29368
6. Jullien J., and Gurdon J. Morphogen gradient interpretation by a regulated trafficking step during ligand-receptor transduction. Genes Dev 19 (2005) 2682-2694
7. Ogunjimi A.A., Briant D.J., Pece-Barbara N., Le Roy C., Di Guglielmo G.M., Kavsak P., Rasmussen R.K., Seet B.T., Sicheri F., and Wrana J.L. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell 19 (2005) 297-308
8. Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., and Wrana J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell 6 (2000) 1365-1375
9. Yamashita M., Ying S.-X., Zhang G.-M., Li C., Cheng S.Y., Deng C.-X., and Zhang Y.E. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121 (2005) 101-113
10. Seo S.R., Lallemand F., Ferrand N., Pessah M., L'Hoste S., Camonis J., and Atfi A. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J 23 (2004) 3780-3792
11. Komuro A., Imamura T., Saitoh M., Yoshida Y., Yamori T., Miyazono K., and Miyazawa K. Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene 23 (2004) 6914-6923
12. Kuratomi G., Komuro A., Goto K., Shinozaki M., Miyazawa K., Miyazono K., and Imamura T. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J 386 (2005) 461-470
13. Su Y, Zhang L, Gao X, Meng F, Wen J, Zhou H, Meng A, Chen YG: The evolutionally conserved activity of Dapper2 in antagonizing TGF-β signaling. FASEB J 2007, in press.
14. Bennett D., and Alphey L. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster. Nat Genet 31 (2002) 419-423
15. Shi W., Sun C., He B., Xiong W., Shi X., Yao D., and Cao X. GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor. J Cell Biol 164 (2004) 291-300
16. Valdimarsdottir G., Goumans M.-J., Itoh F., Itoh S., Heldin C.-H., and ten Dijke P. Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells. BMC Cell Biol 7 (2006) 16
17. Satow R., Kurisaki A., Chan T.-c., Hamazaki T.S., and Asashima M. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell 11 (2006) 763-774. Dullard, which is essential for neural development in Xenopus, functions as an inhibitor for BMP signaling. It mediates ubiquitin-dependent degradation of BMP receptor complex via lipid-raft-caveolar pathway, and has the ability to repress BMP-dependent phosphorylation of the BMP type I receptor. The phosphatase activity of Dullard is absolutely essential for Dullard to degrade BMP receptors.
18. Onichtchouk D., Chen Y.-G., Dosch R., Gawantka V., Delius H., Massagué J., and Niehrs C. Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401 (1999) 480-485
19. Jin W., Kim B.-C., Tognon C., Lee H.-J., Patel S., Lannon C.L., Maris J.M., Triche T.J., Sorensen P.H., and Kim S.-J. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-β signaling by inactivating the TGF-β type II receptor. Proc Natl Acad Sci U S A 102 (2005) 16239-16244
20. Sammar M., Stricker S., Schwabe G.C., Sieber C., Hartung A., Hanke M., Oishi I., Pohl J., Minami Y., Sebald W., et al. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 9 (2004) 1227-1238
21. Lo R.S., and Massagué J. Ubiquitin-dependent degradation of TGF-β-activated Smad2. Nat Cell Biol 1 (1999) 472-478
22. Inman G.J., Nicolás F.J., and Hill C.S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 10 (2002) 283-294
23. Xu L., Kang Y., Çöl S., and Massagué J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFβ signaling complexes in the cytoplasm and nucleus. Mol Cell 10 (2002) 271-282
24. Chen H.B., Shen J., Ip Y.T., and Xu L. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev 20 (2006) 648-653. RNAi-based screening in Drosophila S2 cells is used to identify PDP, which is required for dephosphorylation of MAD. PDP directly dephosphorylates MAD and inhibits Dpp signaling. Mammalian homolog PDP can catalyze dephosphorylation of C-terminal phosphoserine residues in Smad1, but not in Smad2 and Smad3.
25. Lin X., Duan X., Liang Y.-Y., Su Y., Wrighton K.H., Long J., Hu M., Davis C.M., Wang J., Brunicardi F.C., et al. PPM1A functions as a Smad phosphatase to terminate TGFβ signaling. Cell 125 (2006) 915-928. Using a functional genomic approach, PPM1A is identified as a specific phosphatase for Smad2 and Smad3. PPM1A dephosphorylates C-terminal phosphoserine residues of Smad2 and Smad3 and promotes nuclear export of these Smads. Gain-of-function and loss-of-function studies indicate perturbation and enhancement of TGF-β-induced responses, respectively.
26. Duan X., Liang Y.-Y., Feng X.-H., and Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 281 (2006) 36526-36532. PP1A dephosphorylates C-terminal phosphoserine residues in BMP R-Smads as well as those in TGF-β/activin R-Smads. PPM1A physiologically interacts with Smad1 and blocks BMP-induced responses.
27. Knockaert M., Sapkota G., Alarcón C., Massagué J., and Brivanlou A.H. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A 103 (2006) 11940-11945. SCP, originally identified as an inducer of secondary axis of Xenopus embryo, is demonstrated to mitigate BMP signaling. The inhibitory activity of BMP signaling is dependent on its phosphatase activity. Indeed, SCP can bind to phosphorylated Smad1 and catalyze dephosphorylation of C-terminal phosphoserine residues in Smad1 to terminate BMP signaling.
28. Sapkota G., Knockaert M., Alarcón C., Montalvo E., Brivanlou A.H., and Massagué J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem 281 (2006) 40412-40419. SCPs(1-3) can dephosphorylate linker regions of Smad1, Smad2 and Smad3. Specific knock-down for SCP1 and 2 enhances phosphorylation of both the linker region and two C-terminal serines in Smad1, whereas only the linker region of Smad2 and Smad3 is hyperphosphorylated by loss-of-function for SCP1 and 2. It is proposed that SCPs enhance TGF-β signaling and reset Smad1 to the basal unphosphorylated state.
29. Wrighton K.H., Willis D., Long J., Liu F., Lin X., and Feng X.-H. Small carboxy-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance TGF-β signaling. J Biol Chem 281 (2006) 38365-38375. SCPs which possess serine/threonine phosphatase activity, catalyze dephosphorylation of MH1 and linker regions in Smad2 and Smad3. Loss-of-function of SCP enhances the linker phosphorylation of Smad2 or Smad3, while overexpression of SCP enhances TGF-β-mediated responses.
30. Izzi L., and Attisano L. Regulation of the TGFβ signaling pathway by ubiquitin-mediated degradation. Oncogene 23 (2004) 2071-2078
31. Lin X., Liang M., and Feng X.-H. Smurf2 is an ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J Biol Chem 275 (2000) 36818-36822
32. Bonni S., Wang H.R., Causing C.G., Kavsak P., Stroschein S.L., Luo K., and Wrana J.L. TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3 (2001) 587-595
33. Bai Y., Yang C., Hu K., Elly C., and Liu Y.-C. Itch E3 ligase-mediated regulation of TGF-β signaling by modulating Smad2 phosphorylation. Mol Cell 15 (2004) 825-831
34. Xin H., Xu X., Linyu L., Ning H., Rong Y., Shang Y., Wang Y., Fu X.-Y., and Chang Z. CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem 280 (2005) 20842-20850
35. Li L., Xin H., Xu X., Huang M., Zhang X., Chen Y., Zhang S., Fu X.-Y., and Chang Z. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol 24 (2004) 856-864
36. β-TrCP1. J Biol Chem 279 (2004) 14484-14487
37. Morén A., Imamura T., Miyazono K., Heldin C.-H., and Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 280 (2005) 22115-22123
38. Skp2. Mol Cell Biol 24 (2004) 7524-7537
39. Dupont S., Zacchigna L., Cordenonsi M., Soligo S., Adorno M., Rugge M., and Piccolo S. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121 (2005) 87-99. In a functional screen for ectodermmal determinants, Ectodermin (Ecto) is identified. Ecto is a ring-type ubiquitin ligase for Smad4, and is proposed to have a pivotal role in controlling TGF-β-induced responses during embryogenesis and cell proliferation.
40. Li J., and Li W.X. A novel function of Drosophila elF4A as a negative regulator of Dpp/BMP signaling that mediates SMAD degradation. Nat Cell Biol 8 (2006) 1407-1414. Dominant negative elF4A has been known to act as a suppressor of dpp haploinsufficiency in Drosophila. elF4A can induce Mad and Medea degradation in a translation-independent manner, and acts synergistically with, but independently of, DSmurf.
41. Krakowski A.R., Laboureau J., Mauviel A., Bissell M.J., and Luo K. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-β signaling by sequestration of the Smad proteins. Proc Natl Acad Sci USA 102 (2005) 12437-12442
42. Lin F., Morrison J.M., Wu W., and Worman H.J. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-β signaling. Hum Mol Genet 14 (2005) 437-445
43. Pan D., Estévez-Salmerón L.D., Stroschein S.L., Zhu X., He J., Zhou S., and Luo K. The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-β superfamily of cytokines. J Biol Chem 280 (2005) 15992-16001
44. Remy I., Montmarquette A., and Michnick S.W. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6 (2004) 358-365
45. Conery A.R., Cao Y., Thompson E.A., Townsend Jr. C.M., Ko T.C., and Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol 6 (2004) 366-372
46. Song K., Wang H., Krebs T.L., and Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J 25 (2006) 58-69
47. He W., Dorn D.C., Erdjument-Bromage H., Tempst P., Moore M.A., and Massagué J. Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway. Cell 125 (2006) 929-941. TIFγ is identified as a binding partner of phosphorylated Smad2 by proteomic analysis. TIFγ blocks TGF-β/Smad4-mediated responses because TIFγ competes with Smad4 for the interaction with Smad2 and/or Smad3. In erythrocyte differentiation from hematopoietic stem cells by TGF-β, TIFγ stimulates differentiation together with Smad2 and/or Smad3, whereas Smad4 mediates anti-proliferative responses with Smad2 and/or Smad3. The balance between R-Smad/TIFγ- and R-Smad/Smad4-mediated TGF-β signals in erythrocyte differentiation is critical for hematopoietic fate.
48. Gomis R.R., Alarcón C., Nadal C., Van Poznak C., and Massagué J. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10 (2006) 203-214. CEBP/β is found to be essential for TGF-β-induced activation of the p15INK4b promoter and repression of the c-Myc promoter in epithelial cells, two important target genes in the cytostatic response by TGF-β. Breast cancers are found to be resistant to TGF-β-induced cytostatic response, because of their excess expression of the C/EBPβ inhibitor LIP.
49. Zhu O., Krakowski A.R., Dunham E.E., Wang L., Bandyopadhyay A., Berdeaux R., Martin G.S., Sun L., and Luo K. Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 27 (2007) 324-339
50. Takaesu N.T., Hyman-Walsh C., Ye L., Wisotzkey R.G., Stinchfield M.J., O'Connor M.B., Wotton D., and Newfeld S.J. dSno facilitates baboon signaling in the Drosophila brain by switching the affinity of Medea away from Mad and toward dSmad2. Genetics 174 (2006) 1299-1313
51. Monteleone G., Del Vecchio Blanco G., Monteleone I., Fina D., Caruso R., Gioia V., Ballerini S., Federici G., Bernardini S., Pallone F., et al. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129 (2005) 1420-1429
52. Monteleone G., Pallone F., and MacDonald T.T. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trend Immunol 25 (2004) 513-517
53. Wicks S.J., Haros K., Maillard M., Song L., Cohen R.E., ten Dijke P., and Chantry A. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene 24 (2005) 8080-8084
54. Simonsson M., Heldin C.H., Ericsson J., and Gronroos E. The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem 280 (2005) 21797-21803
55. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isshiki K., Isono M., Uzu T., Guarente L., Kashiwagi A., et al. SIRT1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 282 (2007) 151-158
56. Koinuma D., Shinozaki M., Komuro A., Goto K., Saitoh M., Hanyu A., Ebina M., Nukiwa T., Miyazawa K., Imamura T., and Miyazono K. Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J 22 (2003) 6458-6470
57. Liu W., Rui H., Wang J., Lin S., He Y., Chen M., Li Q., Ye Z., Zhang S., Chan S.C., et al. Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO J 25 (2006) 1646-1658
58. Mavrakis KJ, Andrew RL, Lee KL, Petropoulou C, Dixon JE, Navaratnam N, Norris DP, Episkopou V: Arkadia enhances Nodal/TGF-β signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol 2007, in press. Arkadia is shown to enhance Nodal signaling by coupling high phosphoSmad2/3 activity and turnover via a mechanism that depends on Arkadia ubiquitin ligase activity and Smad2/3 interaction.
59. Jenkins B.J., Grail D., Nheu T., Najdovska M., Wang B., Waring P., Inglese M., McLoughlin R.M., Jones S.A., Topley N., et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med 11 (2005) 845-852
60. Wang H.-R., Zhang Y., Ozdamar B., Ogunjimi A.A., Alexandrova E., Thomsen G.H., and Wrana J.L. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302 (2003) 1775-1779
61. Han G., Li A.G., Liang Y.-Y., Owens P., He W., Lu S., Yoshimatsu Y., Wang D., ten Dijke P., Lin X., et al. Smad7-induced β-catenin degradation alters epidermal appendage development. Dev Cell 11 (2006) 301-312. Overexpression of Smad7 in mouse epidermis blocks hair follicle morphogenesis and differentiation, but accelerates sebaceous gland morphogenesis. Smad7 in epidermis associates with β-catenin, after which β-catenin is degraded via recruitment of Smurf2 to the complex. Double transgenic mice for Smurf2 and Smad7 in epidermis aggravates the abnormality seen in Smad7 transgenic mouse, and knock-down of Smad7 increases Wnt signaling in keratinocytes. Thus, Smad7 antagonizes Wnt/β-catenin signaling to alter skin differentiation program.
62. Zhao M., Qiao M., Oyajobi B.O., Mundy G.R., and Chen D. E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278 (2003) 27939-27944
63. Choi K.-C., Lee Y.S., Lim S., Choi H.K., Lee C.-H., Lee E.-K., Hong S., Kim I.-H., Kim S.-J., and Park S.H. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7 (2006) 1057-1065. Smad6 induced by TGF-β and/or BMP associates with Pellino-1, which is a scaffold protein for the MyD88-IRAK-TRAF6 complex critical for IL-1 receptor and TLR signaling. Complex formation between Smad6 and Pellino-1 abrogates the NFκB pathway activated by MyD88-IRAK-TRAF6 signaling. Smad6 is proposed as a mediator of anti-inflammatory effects downstream of TGF-β or BMP signaling by negatively regulating IL-1 receptor and TLR signaling.